PRPL

Procter & Gamble (PG) reported Q1 FY27 core EPS of $2.00, up 1% YoY and beating consensus estimates of $1.89. Net sales rose 4% to $23.28B with 4% organic sales growth driven by volume and favorable mix.

The company raised FY27 sales guidance to 2-4% but maintained core EPS guidance of $6.89-$7.11. Core operating margins contracted 80 bps due to elevated commodity costs and product reinvestments, despite 250 bps in productivity savings.

Procter & Gamble is set to report Q1 fiscal 2027 results on October 22, with sales projected to rise 1.4% to $22.7B but EPS expected to decline 5%. Higher input costs and inflation are pressuring gross margins, projected to contract 120 basis points. While the company benefits from innovation and pricing strategies, valuation concerns persist with a forward P/E of 22.02X, above industry averages.

Kimberly-Clark (KMB) maintains resilience with its 10th consecutive quarter of solid volume-and-mix performance and stable market share despite moderating category growth. North American category growth slowed to 1.9% in Q2 2026 amid consumer pressures, while the company achieved notable market-share gains in international markets like Indonesia (390 basis points in diapers) and Brazil (70 basis points). However, Zacks rates KMB as a Sell with shares down 7.7% in three months, and consensus estimates project minimal earnings growth ahead.